Similarly, a study of 60 childhood, adolescent, and young adult cancer survivors by Smitherman et al. found that p16INK4a expression was, on average, higher among frail cancer survivors compared to the expression in pre-frail (p-value = 0.23) and robust (p-value = 0.055) survivors [53]. The gene discussed is CDKN2A; the disease is cancer.